Case Report
Published on 01 Aug 2024
Case report: DKRd regimen in the treatment of newly diagnosed POEMS syndrome and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1417380
- 1,283 views
Type at least 3 characters
1,822 articles
Case Report
Published on 31 Jul 2024
Case report: An intriguing case of Philadelphia chromosome–positive acute lymphoblastic leukemia recurrence
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1457832
- 1,370 views
Systematic Review
Published on 31 Jul 2024
Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1362367
- 1,211 views
Systematic Review
Published on 31 Jul 2024
Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1341631
- 1,251 views
Review
Published on 29 Jul 2024
Therapeutic options for chronic myeloid leukemia following the failure of second-generation tyrosine kinase inhibitor therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1446517
- 2,245 views
Review
Published on 29 Jul 2024
Novel insights and therapeutic approaches in secondary AML
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1400461
- 3,100 views
- 3 citations
Original Research
Published on 29 Jul 2024
Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1407003
- 2,128 views
Review
Published on 26 Jul 2024
The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1414102
- 2,078 views
Review
Published on 24 Jul 2024
Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1382872
- 4,452 views
- 1 citation
Original Research
Published on 19 Jul 2024
Hypoxanthine in the microenvironment can enable thiopurine resistance in acute lymphoblastic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1440650
- 1,365 views
Review
Published on 19 Jul 2024
Obstacles to global implementation of CAR T cell therapy in myeloma and lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1397613
- 3,405 views
- 3 citations
Mini Review
Published on 18 Jul 2024
Immune checkpoint inhibitors targeting PD-1/PD-L1 in the treatment of human lymphomas
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1420920
- 2,171 views
- 5 citations
Systematic Review
Published on 18 Jul 2024
A systematic review and meta-analysis on utilizing anti-CD19 chimeric antigen receptor T-cell therapy as a second-line treatment for relapsed and refractory diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1407001
- 2,109 views
Case Report
Published on 18 Jul 2024
Familial 46, XY Disorder of Sexual Development identified in a Ph+BCR::ABL1P210+ Acute Lymphoblastic Leukemia septuagenarian female with RCBTB2::LPAR6 fusion gene: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1339737
- 1,112 views
Review
Published on 17 Jul 2024
Advancements in microenvironment-based therapies: transforming the landscape of multiple myeloma treatment
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1413494
- 2,066 views
- 3 citations
Editorial
Published on 16 Jul 2024
Editorial: Biological and clinical implications of the mutational landscape in myeloproliferative neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1454837
- 1,018 views
- 1 citation